Read as much as you want on, anywhere and anytime, for just 99¢.

Celtics Live



4th Quarter 7:23

Bruins Live



2nd Prd 7:30

Mass. Movers

Boston Scientific to buy Bard unit for $275m

Michael Mahoney is the president an CEO of Boston Scientific.

Michael Mahoney is the president an CEO of Boston Scientific.

Natick medical device company Boston Scientific Corp. said it agreed to pay $275 million in cash to buy Bard EP, the electrophysiology business of C.R. Bard. The deal is expected to broaden the range of products Boston Scientific can offer to treat abnormal heartbeats and other cardiac problems. Electrophysiology is a $2.5 billion global market that is growing at nearly 10 percent annually. Bard EP is based in Lowell. The company generated sales of $111 million in 2012. The deal is expected to close later this year.

Loading comments...
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of